logo
  • About us
    • Reig Jofre in brief
    • Strategic pillars
    • Company history
    • Locations
  • Products
    • Product categories
    • Pharmaceutical Technologies
      • Antibiotics
      • Injectable products
      • Others
    • Specialty Products
      • Dermatology
      • Osteoarticular
      • Women’s Health
      • Pediatrics
    • Consumer healthcare
    • Healthcare professionals
      and consumers corner
  • R&D
    • R&D
    • Innovation in Collaboration
    • Pipeline
    • Joint projects
  • Services
    • CDMO services
    • CMO services
  • Investors
    • Information note
    • General information
    • Inside information
    • Other relevant information
    • Former relevant facts
    • Financial information
    • Corporate governance
    • General shareholders’ meetings
    • The share
    • Analysts covering the stock
    • Presentations
    • Webcasts
  • News
    • News and repository
    • Reig Jofre in the media (ES)
    • Subscription center
  • Social Responsibility
  • Contact
    • Contact form
    • Work with us
    • Subscription center
  • |
  • ES
  • EN

News

Transparency withour stakeholders

2017
  1. Home
  2. Archive by Category "2017"

29 December 2017

Administrative merger by absorption

15 December 2017

Transactions within the share buyback program

11 December 2017

Transactions within the share buyback program

1 December 2017

Transactions within the share buyback program

14 November 2017

Results note: Third quarter of 2017

13 November 2017

Appointment of Alain Boutboul as General Manager of Forté Pharma France

10 November 2017

Appointment of Mr. Alejandro Garcia Reig, as Vice President of Reig Jofre

7 November 2017

Transactions within the share buyback program

31 October 2017

Expansion of the product portfolio of Forté Pharma

26 October 2017

Appointments at the head of the corporate and financial management

24 October 2017

Transactions within the share buyback program

24 October 2017

First social-health research worldwide on the use of seawater in respiratory tract diseases

9 October 2017

Transactions within the share buyback program

26 September 2017

Transactions within the share buyback program

13 September 2017

Reig Jofre informs on the launch of Otospray

7 September 2017

Admision to trading of the new shares from the scrip dividend

6 September 2017

Reig Jofre informs on the new commercial activity in the Philippines

4 September 2017

Transactions within the share buyback program

22 August 2017

Transactions within the share buyback program

27 July 2017

Results note: First half of 2017

  • 1
  • 2
  • 3

Legal advice – Online store access for employees – RJF connected

© 2020 Laboratorio Reig Jofre

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsRead MoreAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT

Privacy Preference Center

Privacy Preferences